200 related articles for article (PubMed ID: 37397902)
1. Evaluating treatment options for cardiovascular autonomic neuropathy in patients with diabetes mellitus: a systematic review.
Goh JK; Koh L
Diabetol Int; 2023 Jul; 14(3):224-242. PubMed ID: 37397902
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials.
Wang R; Ye H; Zhao Y; Wei J; Wang Y; Zhang X; Wang L
BMC Med; 2022 Dec; 20(1):487. PubMed ID: 36527023
[TBL] [Abstract][Full Text] [Related]
4. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.
Serhiyenko VA; Serhiyenko AA
World J Diabetes; 2018 Jan; 9(1):1-24. PubMed ID: 29359025
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of epalrestat plus α-lipoic acid combination therapy
Zhao M; Chen JY; Chu YD; Zhu YB; Luo L; Bu SZ
Neural Regen Res; 2018 Jun; 13(6):1087-1095. PubMed ID: 29926837
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
Didangelos T; Karlafti E; Kotzakioulafi E; Kontoninas Z; Margaritidis C; Giannoulaki P; Kantartzis K
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114210
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of seven Chinese patent medicines for early diabetic kidney disease: A Bayesian network meta-analysis.
Zhao J; Ai J; Mo C; Shi W; Meng L
Complement Ther Med; 2022 Aug; 67():102831. PubMed ID: 35398481
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?
Serhiyenko VA; Serhiyenko AA
World J Diabetes; 2015 Mar; 6(2):245-58. PubMed ID: 25789106
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734
[TBL] [Abstract][Full Text] [Related]
12. Abnormal indices of autonomic function are no longer predictors of poor outcome in diabetic patients without neuropathy but with coexisting coronary artery disease who receive optimal pharmacological therapy.
Ponikowska B; Jankowska EA; Reczuch K; Wegrzynowska-Teodorczyk K; Witkowski T; Rydlewska A; Borodulin-Nadzieja L; Banasiak W; Francis D; Ponikowski P
Kardiol Pol; 2009 Dec; 67(12):1325-32. PubMed ID: 20054763
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Vitamin B12 Supplementation on Clinical Outcomes in Patients With Diabetic Neuropathy: A Meta-Analysis of Randomized Controlled Trials.
Karedath J; Batool S; Arshad A; Khalique S; Raja S; Lal B; Anirudh Chunchu V; Hirani S
Cureus; 2022 Nov; 14(11):e31783. PubMed ID: 36457818
[TBL] [Abstract][Full Text] [Related]
14. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Hansen CS; Jensen JS; Ridderstråle M; Vistisen D; Jørgensen ME; Fleischer J
J Diabetes Complications; 2017 Jan; 31(1):202-208. PubMed ID: 27638143
[TBL] [Abstract][Full Text] [Related]
15. Exploring the effectiveness of vitamin B
Lekhanya PK; Mokgalaboni K
BMJ Open; 2022 Aug; 12(8):e065630. PubMed ID: 36008079
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
Ji Y; Yang K; Xiao B; Lin J; Zhao Q; Bhuva MS; Yang H
J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
[TBL] [Abstract][Full Text] [Related]
17. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
[TBL] [Abstract][Full Text] [Related]
18. The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines ± Trastuzumab: a Meta-analysis of clinical studies.
Elghazawy H; Venkatesulu BP; Verma V; Pushparaji B; Monlezun DJ; Marmagkiolis K; Iliescu CA
Crit Rev Oncol Hematol; 2020 Sep; 153():103006. PubMed ID: 32777728
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.
Du YH; Guan CJ; Li LY; Gan P
Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy: systematic review and meta-analysis.
Hu X; Li S; Yang G; Liu H; Boden G; Li L
PLoS One; 2014; 9(2):e87096. PubMed ID: 24533052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
